11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE
NCT02519075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2020-10-01
Summary
Prospective exploratory study specifically investigating the diagnostic and predictive role of 11C-Choline PET/CT and DWI MRI for response assessment in patients affected by HCC and candidate to TARE. A minimum number of 20 patients will be considered for the analysis.
Conditions
- Hepatocarcinoma
Interventions
- OTHER
-
No intervention
Observational study
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Egesta Lopci, MD · Humanitas Clinical and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Italy
Study Locations
More Related Trials
-
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
NCT05957250 ·Status: RECRUITING ·Phase: NA
-
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
NCT00081094 ·Status: COMPLETED ·Phase: NA
-
18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma
NCT05871892 ·Status: RECRUITING ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
NCT03839706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
NCT01485679 ·Status: COMPLETED ·Phase: NA
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
11C-acetate for Treatment Response After Radiotherapy for HCC
NCT02549755 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)
NCT01050283 ·Status: TERMINATED ·Phase: PHASE1
-
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma
NCT03430635 ·Status: COMPLETED
-
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
NCT02245217 ·Status: COMPLETED ·Phase: NA
-
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
NCT05141643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
NCT07252076 ·Status: RECRUITING
-
Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma
NCT01157013 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma
NCT02775786 ·Status: COMPLETED ·Phase: NA
-
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
NCT00842790 ·Status: COMPLETED
-
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
NCT02519049 ·Status: COMPLETED
-
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
NCT06148155 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer
NCT06203613 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors
NCT06203574 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
NCT03636607 ·Status: WITHDRAWN ·Phase: NA
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma
NCT02028377 ·Status: COMPLETED ·Phase: NA
-
Prospective Tumor Response Evaluation
NCT02787954 ·Status: TERMINATED
-
Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors
NCT07178587 ·Status: RECRUITING ·Phase: NA